These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7587975)

  • 1. Absence of acute cocaine interactions with the MAO-B inhibitor selegiline.
    Haberny KA; Walsh SL; Ginn DH; Wilkins JN; Garner JE; Setoda D; Bigelow GE
    Drug Alcohol Depend; 1995 Jul; 39(1):55-62. PubMed ID: 7587975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal selegiline and intravenous cocaine: safety and interactions.
    Houtsmuller EJ; Notes LD; Newton T; van Sluis N; Chiang N; Elkashef A; Bigelow GE
    Psychopharmacology (Berl); 2004 Feb; 172(1):31-40. PubMed ID: 14605792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.
    Bitsios P; Langley RW; Tavernor S; Pyykkö K; Scheinin M; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 1998 Jun; 45(6):551-8. PubMed ID: 9663810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmethylselegiline, a metabolite of selegiline, is an irreversible inhibitor of monoamine oxidase type B in humans.
    Heinonen EH; Anttila MI; Karnani HL; Nyman LM; Vuorinen JA; Pyykkö KA; Lammintausta RA
    J Clin Pharmacol; 1997 Jul; 37(7):602-9. PubMed ID: 9243353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressor response to tyramine after single 24-hour application of a selegiline transdermal system in healthy males.
    Barrett JS; Hochadel TJ; Morales RJ; Rohatagi S; DeWitt KE; Watson SK; Darnow J; Azzaro AJ; DiSanto AR
    J Clin Pharmacol; 1997 Mar; 37(3):238-47. PubMed ID: 9089426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion.
    Harris DS; Everhart T; Jacob P; Lin E; Mendelson JE; Jones RT
    BMC Clin Pharmacol; 2009 Aug; 9():13. PubMed ID: 19646280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6 mg/24 h in healthy subjects.
    Azzaro AJ; Vandenberg CM; Blob LF; Kemper EM; Sharoky M; Oren DA; Campbell BJ
    J Clin Pharmacol; 2006 Aug; 46(8):933-44. PubMed ID: 16855078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence.
    Elkashef A; Fudala PJ; Gorgon L; Li SH; Kahn R; Chiang N; Vocci F; Collins J; Jones K; Boardman K; Sather M
    Drug Alcohol Depend; 2006 Dec; 85(3):191-7. PubMed ID: 16730924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet monoamine oxidase type B by selegiline.
    Heinonen EH; Anttila MI; Nyman LM; Pyykkö KA; Vuorinen JA; Lammintausta RA
    J Clin Pharmacol; 1997 Jul; 37(7):597-601. PubMed ID: 9243352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selegiline effects on cocaine-induced changes in medial temporal lobe metabolism and subjective ratings of euphoria.
    Bartzokis G; Beckson M; Newton T; Mandelkern M; Mintz J; Foster JA; Ling W; Bridge TP
    Neuropsychopharmacology; 1999 Jun; 20(6):582-90. PubMed ID: 10327427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive assessment of the safety of intravenous methamphetamine administration during treatment with selegiline.
    Newton TF; De La Garza R; Fong T; Chiang N; Holmes TH; Bloch DA; Anderson A; Elkashef A
    Pharmacol Biochem Behav; 2005 Dec; 82(4):704-11. PubMed ID: 16413604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder.
    Amsterdam JD
    J Clin Psychiatry; 2003 Feb; 64(2):208-14. PubMed ID: 12633131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and absolute bioavailability of selegiline following treatment of healthy subjects with the selegiline transdermal system (6 mg/24 h): a comparison with oral selegiline capsules.
    Azzaro AJ; Ziemniak J; Kemper E; Campbell BJ; VanDenBerg C
    J Clin Pharmacol; 2007 Oct; 47(10):1256-67. PubMed ID: 17715422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous cocaine are partially attenuated by haloperidol.
    Sherer MA; Kumor KM; Jaffe JH
    Psychiatry Res; 1989 Feb; 27(2):117-25. PubMed ID: 2652168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
    Chen JJ; Swope DM; Dashtipour K
    Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine alters the effects of intravenous cocaine in humans.
    Walsh SL; Preston KL; Sullivan JT; Fromme R; Bigelow GE
    J Clin Psychopharmacol; 1994 Dec; 14(6):396-407. PubMed ID: 7884020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced cardiovascular effects of methamphetamine following treatment with selegiline.
    Schindler CW; Gilman JP; Graczyk Z; Wang G; Gee WL
    Drug Alcohol Depend; 2003 Nov; 72(2):133-9. PubMed ID: 14636968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial.
    Feiger AD; Rickels K; Rynn MA; Zimbroff DL; Robinson DS
    J Clin Psychiatry; 2006 Sep; 67(9):1354-61. PubMed ID: 17017821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome.
    Gitlin MJ
    J Clin Psychopharmacol; 1997 Feb; 17(1):66-7. PubMed ID: 9004070
    [No Abstract]   [Full Text] [Related]  

  • 20. The serotonin-2C agonist Lorcaserin delays intravenous choice and modifies the subjective and cardiovascular effects of cocaine: A randomized, controlled human laboratory study.
    Pirtle JL; Hickman MD; Boinpelly VC; Surineni K; Thakur HK; Grasing KW
    Pharmacol Biochem Behav; 2019 May; 180():52-59. PubMed ID: 30811963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.